Indefinite Delivery Contract SPE2DR25D6045

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The $999,999,999 contract, which has a period of performance through December 2036, serves as a primary vehicle for the government to procure critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas.

The original solicitation, expected to be issued in March 2024, seeks to establish multiple Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet. The procurement is structured as a firm-fixed price, requirements-type contract with a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. Awards will be made on a regional basis, with the intent to have at least three different contractors to ensure resiliency and access to vital pharmaceuticals during contingencies or natural disasters.